Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06324994
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-22
First Post:
2024-03-09
Brief Title:
Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma
Sponsor:
Dalian Medical University
Organization:
Dalian Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-09
First Submit QC Date:
March 15 2024
Study First Post Date:
2024-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-15
Last Update Post Date:
2024-03-22
Last Update Post Date Type:
ACTUAL